Actelion.com

Actelion. Manageable condition, so that patients can live a normal life.

Today's Actelion.com headlines: Observe fresh posts and updates on Actelion. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Actelion.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Actelion

Subscribe to related news

Johnson & Johnson snaps up Swiss biotech firm in $30bn deal
via siliconrepublic

Johnson & Johnson, the world’s largest healthcare giant, is not resting on its laurels after a profit warning was issued earlier this week, swooping in to snap up a major competitor in Europe. Costing $30bn in cash, the deal to acquire Actelion...
Johnson & Johnson to acquire all of the outstanding shares of Actelion for $280 per share payable in U.S. dollars
via news.europawire

In the previous press release the companies omitted the cash amount with which R&D NewCo will launch. This has now been rectified and noted as CHF 1 billion. Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash Tender Offer to be...
Johnson & Johnson to Acquire Actelion for $30 Billion
via diversityinc

Johnson & Johnson (No. 8 on the DiversityInc Top 50 Companies list) and Actelion Ltd. announced January 26 that they have entered into a definitive transaction agreement under which Johnson & Johnson will launch an all-cash tender offer in Switzerland...
Johnson & Johnson to buy Actelion for $30 billion
via chaindrugreview

NEW BRUNSWICK, N.J. — Johnson & Johnson has reached an agreement to acquire Switzerland-based biopharmaceutical company Actelion Ltd. for $30 billion in cash. J&J said Actelion’s differentiated, innovative products for pulmonary arterial hypertension...
Johnson & Johnson agrees to acquire biotech company Actelion for $30bn
via europeanceo

Johnson & Johnson CEO Alex Gorsky will be sitting pretty as head of an even larger firm once the deal goes through On January 26, Johnson & Johnson, the world’s largest healthcare company, announced it will acquire Swiss pharmaceuticals and...

Actelion.com popular pages

Pulmonary arterial hypertension

Pulmonary arterial hypertension For over 25 years, we have transformed the treatment landscape for pulmonary arterial hypertension (PAH).” For over 25 years, we have transformed the t...